BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 24838473)

  • 21. A patient-derived iPSC model revealed oxidative stress increases facioscapulohumeral muscular dystrophy-causative DUX4.
    Sasaki-Honda M; Jonouchi T; Arai M; Hotta A; Mitsuhashi S; Nishino I; Matsuda R; Sakurai H
    Hum Mol Genet; 2018 Dec; 27(23):4024-4035. PubMed ID: 30107443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation analysis of clinical parameters with epigenetic modifications in the DUX4 promoter in FSHD.
    Balog J; Thijssen PE; de Greef JC; Shah B; van Engelen BG; Yokomori K; Tapscott SJ; Tawil R; van der Maarel SM
    Epigenetics; 2012 Jun; 7(6):579-84. PubMed ID: 22522912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facioscapulohumeral muscular dystrophy: molecular pathological advances and future directions.
    Statland JM; Tawil R
    Curr Opin Neurol; 2011 Oct; 24(5):423-8. PubMed ID: 21734574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineered FSHD mutations results in D4Z4 heterochromatin disruption and feedforward DUX4 network activation.
    Kong X; Nguyen NV; Li Y; Sakr JS; Williams K; Sharifi S; Chau J; Bayrakci A; Mizuno S; Takahashi S; Kiyono T; Tawil R; Mortazavi A; Yokomori K
    iScience; 2024 Apr; 27(4):109357. PubMed ID: 38510139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemizygosity for SMCHD1 in Facioscapulohumeral Muscular Dystrophy Type 2: Consequences for 18p Deletion Syndrome.
    Lemmers RJ; van den Boogaard ML; van der Vliet PJ; Donlin-Smith CM; Nations SP; Ruivenkamp CA; Heard P; Bakker B; Tapscott S; Cody JD; Tawil R; van der Maarel SM
    Hum Mutat; 2015 Jul; 36(7):679-83. PubMed ID: 25820463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of two novel SMCHD1 sequence variants in families with FSHD-like muscular dystrophy.
    Winston J; Duerden L; Mort M; Frayling IM; Rogers MT; Upadhyaya M
    Eur J Hum Genet; 2015 Jan; 23(1):67-71. PubMed ID: 24755953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of epigenetic silencing of the DUX4 transcription factor gene in facioscapulohumeral muscular dystrophy.
    Hewitt JE
    Hum Mol Genet; 2015 Oct; 24(R1):R17-23. PubMed ID: 26113644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct interplay between two candidate genes in FSHD muscular dystrophy.
    Ferri G; Huichalaf CH; Caccia R; Gabellini D
    Hum Mol Genet; 2015 Mar; 24(5):1256-66. PubMed ID: 25326393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mechanism of translocation between chromosomes 4q and 10q in facioscapulohumeral muscular dystrophy].
    Wang N; Wu ZY; Wang CD; Wang ZQ; Lin MT; Fang L; Murong SX
    Zhonghua Yi Xue Za Zhi; 2003 Apr; 83(8):650-3. PubMed ID: 12887821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wnt/β-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells.
    Block GJ; Narayanan D; Amell AM; Petek LM; Davidson KC; Bird TD; Tawil R; Moon RT; Miller DG
    Hum Mol Genet; 2013 Dec; 22(23):4661-72. PubMed ID: 23821646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A focal domain of extreme demethylation within D4Z4 in FSHD2.
    Hartweck LM; Anderson LJ; Lemmers RJ; Dandapat A; Toso EA; Dalton JC; Tawil R; Day JW; van der Maarel SM; Kyba M
    Neurology; 2013 Jan; 80(4):392-9. PubMed ID: 23284062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy.
    Snider L; Asawachaicharn A; Tyler AE; Geng LN; Petek LM; Maves L; Miller DG; Lemmers RJ; Winokur ST; Tawil R; van der Maarel SM; Filippova GN; Tapscott SJ
    Hum Mol Genet; 2009 Jul; 18(13):2414-30. PubMed ID: 19359275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hybridization analysis of D4Z4 repeat arrays linked to FSHD.
    Ehrlich M; Jackson K; Tsumagari K; Camaño P; Lemmers RJ
    Chromosoma; 2007 Apr; 116(2):107-16. PubMed ID: 17131163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene.
    Snider L; Geng LN; Lemmers RJ; Kyba M; Ware CB; Nelson AM; Tawil R; Filippova GN; van der Maarel SM; Tapscott SJ; Miller DG
    PLoS Genet; 2010 Oct; 6(10):e1001181. PubMed ID: 21060811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation.
    Bodega B; Ramirez GD; Grasser F; Cheli S; Brunelli S; Mora M; Meneveri R; Marozzi A; Mueller S; Battaglioli E; Ginelli E
    BMC Biol; 2009 Jul; 7():41. PubMed ID: 19607661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Remotely acting SMCHD1 gene regulatory elements: in silico prediction and identification of potential regulatory variants in patients with FSHD.
    Mayes MB; Morgan T; Winston J; Buxton DS; Kamat MA; Smith D; Williams M; Martin RL; Kleinjan DA; Cooper DN; Upadhyaya M; Chuzhanova N
    Hum Genomics; 2015 Oct; 9():25. PubMed ID: 26446085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy.
    Lemmers RJ; Wohlgemuth M; van der Gaag KJ; van der Vliet PJ; van Teijlingen CM; de Knijff P; Padberg GW; Frants RR; van der Maarel SM
    Am J Hum Genet; 2007 Nov; 81(5):884-94. PubMed ID: 17924332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facioscapulohumeral dystrophy myoblasts efficiently repair moderate levels of oxidative DNA damage.
    Bou Saada Y; Dib C; Dmitriev P; Hamade A; Carnac G; Laoudj-Chenivesse D; Lipinski M; Vassetzky YS
    Histochem Cell Biol; 2016 Apr; 145(4):475-83. PubMed ID: 26860865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.
    van der Maarel SM; Tawil R; Tapscott SJ
    Trends Mol Med; 2011 May; 17(5):252-8. PubMed ID: 21288772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allele-specific DNA hypomethylation characterises FSHD1 and FSHD2.
    Calandra P; Cascino I; Lemmers RJ; Galluzzi G; Teveroni E; Monforte M; Tasca G; Ricci E; Moretti F; van der Maarel SM; Deidda G
    J Med Genet; 2016 May; 53(5):348-55. PubMed ID: 26831754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.